Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3342
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01540409 | Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy | ||
| NCT03828149 | Evaluation of Safety and Pharmacodynamics of OP0201 Compared to Placebo in Healthy Adults | ||
| NCT01085045 | Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) | ||
| NCT03770572 | Gene Therapy for Children With CLN3 Batten Disease | ||
| NCT04607772 | Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL) | ||
| NCT06897839 | Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD) | ||
| NCT02347072 | 24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003, Open-Label Spiriva® Respimat® as an Active Control, and Placebo | ||
| NCT04350177 | A Study to Assess Single and Multiple Doses of IkT-148009 in Healthy Elderly Participants and Parkinson's Patients | ||
| NCT01593072 | A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers | ||
| NCT01282268 | Efficacy and Safety Study of STX209 (Arbaclofen) for Social Withdrawal in Adolescents and Adults With Fragile X Syndrome | ||
| NCT02117830 | A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male Subjects | ||
| NCT01926028 | Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis | ||
| NCT01776606 | Efficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines | ||
| NCT05639933 | Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors | ||
| NCT06586957 | A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors | ||
| NCT06938711 | A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast Cancer | ||
| NCT03896009 | Maximizing Outcomes in Treating Acute Migraine | ||
| NCT03530852 | A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB | ||
| NCT02657330 | Study of SBP-101 in Pancreatic Cancer | ||
| NCT05665036 | Safety and Efficacy of Encapsulated Allogeneic MPS-1 Therapy | ||
| NCT04669899 | Study of JTX-8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors | ||
| NCT05820152 | Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations | ||
| NCT02964377 | Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents | ||
| NCT00589875 | Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma | ||
| NCT05029401 | A Study of Oral Ibogaine in Opioid Withdrawal | ||
| NCT03609619 | PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations | ||
| NCT05276830 | An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia | ||
| NCT05081167 | A Study to Assess the Efficacy and Safety of REL-1017 as Monotherapy for Major Depressive Disorder (MDD) | ||
| NCT05052567 | CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma | ||
| NCT06546995 | Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease | ||
| NCT05744739 | Tomivosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML) | ||
| NCT06507839 | Study to Assess the Safety, Tolerability, Pharmacokinetic of Thrv-1268 | ||
| NCT03301597 | NLA101 in Adults Receiving High Dose Chemotherapy for AML | ||
| NCT01147172 | Safety Study of Cosmetic Tissue Augmentation in People of Color | ||
| NCT06922591 | Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients | ||
| NCT03226574 | Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for Treatment of Intractable Cancer Pain | ||
| NCT04130997 | An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis | ||
| NCT07059754 | A Clinical Study to Determine What Effect the EyeCool Treatment Has on the Eye's Surface Anatomy and Inflammation Response After Being Treated for Having Chronic Ocular Surface Pain (COSP) | ||
| NCT02670330 | Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa | ||
| NCT05565950 | AI-09 In Subjects With Glabellar Lines, GL-101 | ||
| NCT05448391 | A Study to Evaluate RIST4721 in Familial Mediterranean Fever (FMF) | ||
| NCT03493698 | A Fixed-Sequence, Drug-Drug Interaction Study Between Multiple Oral Doses of Inarigivir Soproxil and a Single Oral Dose of Midazolam in Healthy Subjects | ||
| NCT03271021 | A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris | ||
| NCT05948033 | CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma | ||
| NCT06661148 | Study of EPI-003 in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients | ||
| NCT04057040 | Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE) | ||
| NCT01187043 | Determination of the Lowest, Safe and Effective Dose of Proellex | ||
| NCT06112340 | Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) | ||
| NCT07364513 | Phase 1b Safety Study of IMSB301 in Type 1 Interferonopathies | ||
| NCT01577459 | A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response |
